Through the mouse kidney injury model experiment, SPARCL1 showed that mRNA expression was not changed in the acute phase, but the expression level was high in the fibrosis of the kidney [50], and it inhibited the movement and invasion of renal cell carcinoma [51]. This evidence concerns the gene SPARCL1 and hereditary clear cell renal cell carcinoma.